Skip to main content
OpenTrials

Clinical trial condition

Hepatitis, Viral, Human

Explore clinical trials studying Hepatitis, Viral, Human. Study availability and eligibility vary by location and protocol.

2,914 public trials 161 recruiting studies
Refine in advanced search Browse all conditions

Hepatitis, Viral, Human trial results

Completed

Dose Finding Study of Pegylated-P-Interferon-alpha-2b(P1101) in Treatment-Naive Subjects With Hepatitis C Virus Genotype 1 Infection

NCT01587586

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Changhua Christian Hospital Changhua, Taiwan
  • National Taiwan University Hospital - Yunlin Douliu, Taiwan
  • Kaohsiung Medical University Chung-Ho Memorial Hospital Kaohsiung City, Taiwan
  • Chang Gung Medical Foundation - Kaohsiung Kaohsiung City, Taiwan
View all 13 locations
View Trial Details
Completed

A Study to Evaluate Treatment of Hepatitis C Virus Infection in Pediatric Subjects

NCT02486406

Conditions
Blood-Borne Infections, Chronic Hepatitis C Infection, Communicable Diseases, +9 more
Locations
  • UCSF Benioff Childrens Hosp /ID# 136774 San Francisco, California, United States
  • Children's Hospital Colorado /ID# 137017 Aurora, Colorado, United States
  • University of Florida - Archer /ID# 136830 Gainesville, Florida, United States
  • Advent Health /ID# 167663 Orlando, Florida, United States
View all 21 locations
View Trial Details
Completed

A Safety and Tolerability Study of Nitazoxanide in HIV-HCV Treatment Failures

NCT01185028

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +19 more
Locations
  • Family Medical and Counseling Services, SE Washington D.C., District of Columbia, United States
  • Unity Health Care/Walker Jones, NE Washington D.C., District of Columbia, United States
  • Whitman Walker Clinic, NW Washington D.C., District of Columbia, United States
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) From Tenofovir Disoproxil Fumarate (TDF) and/or Other Oral Antiviral Treatment (OAV)

NCT03180619

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations
  • Coalition of Inclusive Medicine Los Angeles, California, United States
  • Silicon Valley Research Institute, Inc San Jose, California, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Harborview Medical Center Seattle, Washington, United States
View all 30 locations
View Trial Details

Related conditions